New perspectives on complement mediated immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

New perspectives on complement mediated immunotherapy

Published:2016-04 Issue: Volume:45 Page:68-75
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Stasiłojć Grzegorz,Österborg Anders,Blom Anna M.,Okrój Marcin

Funder

National Science Centre

The Cancer Society in Stockholm

The Stockholm County Council

The Swedish Research Council

Malmö Hospitals Foundation for The Fight Against Cancer, AFA, The Cancer and Allergy Foundation

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Reference96 articles.

1. Adoptive immunotherapy for cancer: harnessing the T cell response;Restifo;Nat Rev Immunol,2012

2. Mutant ras epitopes as targets for cancer vaccines;Abrams;Semin Oncol,1996

3. The phospholipid code: a key component of dying cell recognition, tumor progression and host-microbe interactions;Baxter;Cell Death Differ,2015

4. Overexpression of Glut-1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma;Kunkel;Cancer,2003

5. MRI of the tumor microenvironment;Gillies;J Magn Reson Imaging,2002

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Maitake Beta-Glucan Enhances the Therapeutic Effect of Trastuzumab <i>via</i> Antibody-Dependent Cellular Cytotoxicity and Complement-Dependent Cytotoxicity;Biological and Pharmaceutical Bulletin;2024-04-15

2. The Acquisition of Complement-Dependent Cytotoxicity by the Type II Anti-CD20 Therapeutic Antibody Obinutuzumab;Cancers;2023-12-21

3. ATF3 and CH25H regulate effector trogocytosis and anti-tumor activities of endogenous and immunotherapeutic cytotoxic T lymphocytes;Cell Metabolism;2022-09

4. Dual Fc optimization to increase the cytotoxic activity of a CD19-targeting antibody;Frontiers in Immunology;2022-08-31

5. Bispecific mAb2 Antibodies Targeting CD59 Enhance the Complement-Dependent Cytotoxicity Mediated by Rituximab;International Journal of Molecular Sciences;2022-05-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3